Cargando…

Quetiapine Addiction: A Case Report

INTRODUCTION: Quetiapine has been the subject of case reports documenting its abuse. In Morocco, no study has been done showing the prevalence of this misuse. The methods of administration are diverse: oral or nasal, injection, inhalation, consumption with cannabis (smoked) or alcohol, combination w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaara, A., Sabir, M., El Omari, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568151/
http://dx.doi.org/10.1192/j.eurpsy.2022.2136
_version_ 1784809577205727232
author Chaara, A.
Sabir, M.
El Omari, F.
author_facet Chaara, A.
Sabir, M.
El Omari, F.
author_sort Chaara, A.
collection PubMed
description INTRODUCTION: Quetiapine has been the subject of case reports documenting its abuse. In Morocco, no study has been done showing the prevalence of this misuse. The methods of administration are diverse: oral or nasal, injection, inhalation, consumption with cannabis (smoked) or alcohol, combination with other drugs. The abuse is associated in 75% of cases with another product. OBJECTIVES: The objective of this work is to describe the management of quetiapine dependence, through a clinical vignette. METHODS: Through a clinical vignette, and by reviewing the literature, we will describe the management of quetiapine addiction. RESULTS: Treatment consists of reducing the consumption of this substance until stopping. When possible, it is recommended to change this antipsychotic to another with low abuse potential and low antihistamine properties such as haloperidol, risperidone or aripiprazole. If, however, this solution was inapplicable, then limit the quantity of tablets by prescribing smaller amounts of antipsychotics and increase the frequency of visits. Cope and relieve: Sometimes other medicines can be used to relieve potential withdrawal symptoms, including benzodiazepines or hypnotics to manage insomnia. Warnings : Ideally, the drug should be reduced gradually with a gradual and planned decrease in the dose taken over the months. There should also be periodic evaluations. Long term treatment: Management must be biopsychosocial. Treating comorbidities is a fundamental step in preventing relapse. CONCLUSIONS: It is a “prescription” use disorder! Each prescription should be carefully weighed and time bound. It seems important to be vigilant with regard to the dosages administered and the treatment regimens offered to the patients. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9568151
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95681512022-10-17 Quetiapine Addiction: A Case Report Chaara, A. Sabir, M. El Omari, F. Eur Psychiatry Abstract INTRODUCTION: Quetiapine has been the subject of case reports documenting its abuse. In Morocco, no study has been done showing the prevalence of this misuse. The methods of administration are diverse: oral or nasal, injection, inhalation, consumption with cannabis (smoked) or alcohol, combination with other drugs. The abuse is associated in 75% of cases with another product. OBJECTIVES: The objective of this work is to describe the management of quetiapine dependence, through a clinical vignette. METHODS: Through a clinical vignette, and by reviewing the literature, we will describe the management of quetiapine addiction. RESULTS: Treatment consists of reducing the consumption of this substance until stopping. When possible, it is recommended to change this antipsychotic to another with low abuse potential and low antihistamine properties such as haloperidol, risperidone or aripiprazole. If, however, this solution was inapplicable, then limit the quantity of tablets by prescribing smaller amounts of antipsychotics and increase the frequency of visits. Cope and relieve: Sometimes other medicines can be used to relieve potential withdrawal symptoms, including benzodiazepines or hypnotics to manage insomnia. Warnings : Ideally, the drug should be reduced gradually with a gradual and planned decrease in the dose taken over the months. There should also be periodic evaluations. Long term treatment: Management must be biopsychosocial. Treating comorbidities is a fundamental step in preventing relapse. CONCLUSIONS: It is a “prescription” use disorder! Each prescription should be carefully weighed and time bound. It seems important to be vigilant with regard to the dosages administered and the treatment regimens offered to the patients. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9568151/ http://dx.doi.org/10.1192/j.eurpsy.2022.2136 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Chaara, A.
Sabir, M.
El Omari, F.
Quetiapine Addiction: A Case Report
title Quetiapine Addiction: A Case Report
title_full Quetiapine Addiction: A Case Report
title_fullStr Quetiapine Addiction: A Case Report
title_full_unstemmed Quetiapine Addiction: A Case Report
title_short Quetiapine Addiction: A Case Report
title_sort quetiapine addiction: a case report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568151/
http://dx.doi.org/10.1192/j.eurpsy.2022.2136
work_keys_str_mv AT chaaraa quetiapineaddictionacasereport
AT sabirm quetiapineaddictionacasereport
AT elomarif quetiapineaddictionacasereport